{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:16:04Z","timestamp":1788336964526,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jhepr.2026.101855","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T07:57:42Z","timestamp":1775721462000},"page":"101855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Paediatric autoimmune liver disease in Europe, the prospective ERN R-LIVER registry"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6956-7676","authenticated-orcid":false,"given":"Mikkel","family":"Malham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6207-7463","authenticated-orcid":false,"given":"Gema Mu\u00f1oz","family":"Bartolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7170-3959","authenticated-orcid":false,"given":"Antal","family":"Dezs\u00f6fi-Gottl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2608-5087","authenticated-orcid":false,"given":"Steffen","family":"Hartleif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto Hierro","family":"Llanillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7867-0069","authenticated-orcid":false,"given":"Daniel","family":"Teglmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Gerussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7873-4277","authenticated-orcid":false,"given":"Virag","family":"Hives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3099-2667","authenticated-orcid":false,"given":"Norman","family":"Junge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4030-2524","authenticated-orcid":false,"given":"Andrea","family":"Briem-Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0658-4636","authenticated-orcid":false,"given":"Marianne H\u00f8rby","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2026.101855_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN Hepatology Committee Position Statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhepr.2026.101855_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101855_bib3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101855_bib4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/archdischild-2013-303848","article-title":"Paediatric autoimmune liver disease","volume":"98","author":"Mieli-Vergani","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jhepr.2026.101855_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jpeds.2019.11.028","article-title":"Seamless management of juvenile autoimmune liver disease: long-term medical and social outcome","volume":"218","author":"Di Giorgio","year":"2020","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhepr.2026.101855_bib6","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.26454","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history","volume":"58","author":"Deneau","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101855_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/MPG.0000000000002892","article-title":"Presentation and outcomes of autoimmune hepatitis type 1 and type 2 in children: a single-center study","volume":"72","author":"Roepe","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhepr.2026.101855_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jped.2018.04.007","article-title":"Autoimmune hepatitis in 828 Brazilian children and adolescents: clinical and laboratory findings, histological profile, treatments, and outcomes","volume":"95","author":"Porta","year":"2019","journal-title":"J Pediatr (Rio J"},{"key":"10.1016\/j.jhepr.2026.101855_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.dld.2016.03.015","article-title":"Seronegative autoimmune hepatitis in children: spectrum of disorders","volume":"48","author":"Maggiore","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2026.101855_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cld.2005.10.009","article-title":"Autoimmune hepatitis and primary sclerosing cholangitis","volume":"10","author":"Alvarez","year":"2006","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhepr.2026.101855_bib11","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.pcl.2021.07.006","article-title":"Pediatric autoimmune liver diseases: autoimmune hepatitis and primary sclerosing cholangitis","volume":"68","author":"Kemme","year":"2021","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jhepr.2026.101855_bib12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jped.2018.08.001","article-title":"Autoimmune hepatitis in children","volume":"95","author":"Alvarez","year":"2019","journal-title":"J Pediatr (Rio J"},{"key":"10.1016\/j.jhepr.2026.101855_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41424-018-0028-1","article-title":"Role of age in presentation, response to therapy and outcome of autoimmune hepatitis","volume":"9","author":"Baven-Pronk","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jhepr.2026.101855_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.hbpd.2019.08.004","article-title":"Acute onset of autoimmune hepatitis in children and adolescents","volume":"19","author":"Smolka","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jhepr.2026.101855_bib15","article-title":"Biliary disease progression in childhood onset autoimmune liver disease: a 30-year follow-up into adulthood","volume":"6","author":"Warner","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2026.101855_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2009.02.024","article-title":"Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up","volume":"51","author":"Aw","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101855_bib17","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/s10620-018-5011-x","article-title":"Tacrolimus and mycophenolate mofetil as second-line therapies for pediatric patients with autoimmune hepatitis","volume":"63","author":"Efe","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2026.101855_bib18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.mpg.0000235975.75120.38","article-title":"Follow-up of children with autoimmune hepatitis treated with cyclosporine","volume":"43","author":"Cuarterolo","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhepr.2026.101855_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-3476(99)70339-2","article-title":"Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis","volume":"135","author":"Debray","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhepr.2026.101855_bib20","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.jhep.2020.07.023","article-title":"Second-line and third-line therapy for autoimmune hepatitis A position statement from the European reference Network on hepatological diseases and the international autoimmune hepatitis group","volume":"73","author":"Lohse","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101855_bib21","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jpeds.2013.05.042","article-title":"Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents","volume":"163","author":"Woynarowski","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhepr.2026.101855_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/MPG.0000000000002776","article-title":"Autoimmune hepatitis in children: prednisone plus azathioprine vs cyclosporine: a randomized trial","volume":"71","author":"Cuarterolo","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhepr.2026.101855_bib23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s12072-019-09948-1","article-title":"Biliary features in liver histology of children with autoimmune liver disease","volume":"13","author":"Di Giorgio","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2026.101855_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35882-7","article-title":"Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis","volume":"8","author":"Taubert","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2026.101855_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5409\/wjcp.v12.i3.77","article-title":"Seronegative autoimmune hepatitis in childhood","volume":"12","author":"Islek","year":"2023","journal-title":"World J Clin Pediatr"},{"key":"10.1016\/j.jhepr.2026.101855_bib26","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"18","author":"von","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.jhepr.2026.101855_bib27","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1111\/liv.16035","article-title":"Unmet needs in autoimmune hepatitis: results of the prospective multicentre European Reference Network Registry (R-LIVER)","volume":"44","author":"Schregel","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2026.101855_bib28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jhep.2023.01.013","article-title":"Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood","volume":"78","author":"Maggiore","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101855_bib29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1373\/clinchem.2011.177741","article-title":"Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children","volume":"58","author":"Colantonio","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.jhepr.2026.101855_bib30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/MPG.0000000000003268","article-title":"North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Position paper on the diagnosis and management of pediatric acute liver failure","volume":"74","author":"Squires","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhepr.2026.101855_bib31","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101855_bib32","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101855_bib33","first-page":"171","article-title":"Histopathological study of chronic hepatitis B: a comparative study of Ishak and METAVIR scoring systems","volume":"1","author":"Mohamadnejad","year":"2010","journal-title":"Int J Organ Transpl Med"},{"key":"10.1016\/j.jhepr.2026.101855_bib34","unstructured":"www.sankeymatic.com."},{"key":"10.1016\/j.jhepr.2026.101855_bib35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.51821\/84.2.305","article-title":"Seronegative autoimmune hepatitis in children: a single-center experience","volume":"84","author":"Islek","year":"2021","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.jhepr.2026.101855_bib36","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/jpn3.12378","article-title":"Primary sclerosing cholangitis in children with inflammatory bowel disease: an ESPGHAN position paper from the Hepatology Committee and the IBD Porto group","volume":"80","author":"van Rheenen","year":"2025","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhepr.2026.101855_bib37","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1478-3231.2008.01904.x","article-title":"Features and consequences of untreated type 1 autoimmune hepatitis","volume":"29","author":"Czaja","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2026.101855_bib38","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.101855_bib39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis","volume":"1","author":"Murray-Lyon","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2026.101855_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2019.11.013","article-title":"Rapid response to treatment of autoimmune hepatitis associated with remission at 6 and 12 months","volume":"18","author":"Pape","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101855_bib41","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/HEP.0000000000000589","article-title":"Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry","volume":"79","author":"Slooter","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.101855_bib42","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/apt.17994","article-title":"Paediatric-onset immune-mediated inflammatory disease is associated with an increased mortality risk \u2013 a nationwide study","volume":"59","author":"Malham","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2026.101855_bib43","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gronbaek","year":"2014","journal-title":"J Hepatol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926001266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926001266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T07:30:19Z","timestamp":1783582219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555926001266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2589555926001266"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101855","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paediatric autoimmune liver disease in Europe, the prospective ERN R-LIVER registry","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101855"}}